Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Penumbra, Inc. (PEN) vs Smith & Nephew SNATS, Inc. (SNN)

Penumbra, Inc. and Smith & Nephew SNATS, Inc. are both Medical Devices companies. Penumbra, Inc. is the larger, with a market value of $12.6B against $11.2B — 1.1× the size. Smith & Nephew SNATS, Inc. trades at the lower P/E: 32.8× against 78.0×. Penumbra, Inc. grew revenue faster over the last twelve months: 17.6% against 4.81%. Penumbra, Inc. has the higher net margin (10.7% vs 6.71%) and the higher return on invested capital (13.1% vs 0.00%). Across the 22 metrics below, Penumbra, Inc. leads on 12 and Smith & Nephew SNATS, Inc. on 10.

Valuation

Metric PEN SNN Medical Devices median
P/E 77.97 32.80 22.18
P/S 8.34 1.15 2.70
P/B 8.20 2.33 2.46
Price to free cash flow 58.13 5.97 22.53
EV/EBITDA 58.25 5.66 11.78
EV/Sales 7.91 1.39 2.38
Earnings yield 1.28% 3.05% (8.22%)
Free cash flow yield 1.72% 16.74% (7.80%)

Profitability

Metric PEN SNN Medical Devices median
Gross margin 67.84% 70.52% 56.01%
Operating margin 12.45% 0.00% (15.03%)
Net margin 10.67% 6.71% (20.40%)
Free cash flow margin 14.35% 0.00% (7.24%)
Return on equity 11.37% 0.00% (15.32%)
Return on assets 8.80% 0.00% (19.72%)
Return on invested capital 13.13% 0.00% (10.33%)

Growth

Metric PEN SNN Medical Devices median
Revenue growth (TTM) 17.55% 4.81% 8.80%
EPS growth (last fiscal year) 1,155.56% 52.34% —
Revenue growth, 5-year CAGR 20.16% 6.21% 15.23%
Net income growth, 5-year CAGR 0.00% 6.89% 0.00%

Health

Metric PEN SNN Medical Devices median
Debt to equity 0.01 0.62 0.07
Current ratio 5.75 2.14 2.50
Net debt to EBITDA (2.54) 1.92 0.49

Dividend

Metric PEN SNN Medical Devices median
Dividend yield — 2.67% 0.94%
Payout ratio 0.00 1.50 0.00

Size

Metric PEN SNN Medical Devices median
Market cap 12.59b 11.17b 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack